Use of Urinary Cell-Cycle Arrest Biomarkers in Contrast-Associated Nephropathy After Coronary Angiography

CompletedOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions
Contrast-induced Nephropathy
Interventions
DIAGNOSTIC_TEST

Urinary determination of TIMP-2/ IGFBP7

"Urinary determination of TIMP2-IGFBP7 in the an urine sample obtained within 12 hours prior to contrast administration. A single determination will be made, which will be sent to the laboratory. The doctor who treats the patient will not know the result of the test, and the treatment will not be influenced by the result.~According to the manufacturer, 10 ml of fresh urine should be collected in a sterile container and the laboratory should centrifuge them within the time of collection.~The result is reported as a single value calculated as the concentration of TIMP-2 (ng / mL) multiplied by the concentration of IGFBP7 (ng / mL) divided by 1000. The result is reported without units."

Trial Locations (1)

03203

Hospital General Universitario de Elche, Elche

All Listed Sponsors
lead

Eva de Miguel Balsa

OTHER

NCT04163250 - Use of Urinary Cell-Cycle Arrest Biomarkers in Contrast-Associated Nephropathy After Coronary Angiography | Biotech Hunter | Biotech Hunter